Skip to main content
. 2020 Jan 10;21:13. doi: 10.1186/s12931-019-1254-0

Table 1.

Characteristics of Study Populations by PPC Development (N = 321)

Overall (N = 321) Development of PPC
No (N = 242) Yes (N = 79) P Value
Age (years) 61.1 (8.0) 60.4 (8.0) 63.3 (8.0) .006
Sex .017
 Male 289 (80.7) 188 (77.7) 71 (89.9)
 Female 62 (19.3) 54 (22.3) 8 (10.1)
BMI (kg/m2) 23.7 (3.1) 23.8 (3.1) 23.6 (3.1) .670
Smoking status .014
 Never 63 (19.6) 55 (22.7) 8 (10.1)
 Past or current 259 (80.4) 187 (77.3) 71 (89.9)
Histology .120
 Adenocarcinoma 168 (52.3) 134 (55.4) 34 (43.0)
 Squamous cell 128 (39.8) 90 (37.2) 38 (48.1)
 Large cell 9 (2.8) 8 (3.3) 1 (1.3)
 Others 16 (5.0) 10 (4.1) 6 (7.6)
Type of surgery .010
 Lobectomy 256 (79.8) 201 (83.1) 55 (69.6)
 Bilobectomy/Pneumonectomy 65 (20.2) 41 (16.9) 24 (30.4)
PFT before CCRT
 FVC, % of the predicted value 91.7 (15.1) 92.7 (14.8) 88.6 (15.8) .036
 FEV1, % of the predicted value 82.8 (16.6) 84.4 (16.5) 77.8 (15.9) .002
 FEV1/FVC, % 70.2 (9.6) 70.9 (9.4) 68.1 (10.1) .003
 DLco, % of the predicted value 82.0 (17.5) 84.7 (17.7) 73.7 (14.1) <.001
PFT after CCRT
 FVC, % of the predicted value 90.3 (13.7) 91.8 (13) 85.6 (14.8) <.001
 FEV1, % of the predicted value 84.4 (14.6) 85.9 (14.1) 79.8 (15.2) .001
 FEV1/FVC, % 70.8 (9.0) 71.2 (8.7) 69.5 (9.8) .143
 DLco, % of the predicted value 69.7 (15.1) 72 (14.9) 62.8 (13.6) <.001
Hemoglobin
 Before CCRT 13.6 (1.4) 13.6 (1.4) 13.5 (1.6) 0.793
 After CCRT 11.9 (1.5) 11.9 (1.5) 11.9 (1.6) 0.725

Values in table are mean (SD), number (%), or median (interquartile range)

BMI body mass index; CCRT concurrent chemoradiotherapy; DLco diffusing capacity of the lung for carbon monoxide; FEV1 forced expiratory volume in one second; FVC forced vital capacity; PFT pulmonary function test; PPC postoperative pulmonary complications